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Application of allergens onto the sublingual epithelium is used to desensitize allergic
individuals, a treatment known as sublingual immunotherapy. However, the response of
sublingual epithelial cells to house dust mite allergen and potential tolerance-promoting
adjuvants such as Toll-like receptor (TLR) ligands and calcitriol has not been investigated.
In order to study this, primary sublingual epithelial cells were isolated from dogs
and cultured in vitro. After 24-h incubation with a Dermatophagoides farinae extract,
a Dermatophagoides pteronyssinus extract, TLR2 ligands (FSL-1, heat-killed Listeria
monocytogenes, Pam3CSK4), a TLR3 ligand (poly I:C), a TLR4 ligand [lipopolysaccharide
(LPS)], and calcitriol (1,25-dihydroxyvitamin D3), viability of the cells was analyzed using
an MTT test, and their secretion of interleukin 6 (IL-6), IL-10, CXCL8, and transforming
growth factor β1 (TGF-β1) was measured by enzyme-linked immunosorbent assay.
Additionally, to evaluate its potential effect as an adjuvant, sublingual epithelial cells
were incubated with calcitriol in combination with a D. farinae extract followed by
measurement of CXCL8 secretion. Furthermore, the effect of D. farinae and calcitriol
on the transcriptome was assessed by RNA sequencing. The viability of the sublingual
epithelial cells was significantly decreased by poly I:C, but not by the other stimuli.
CXCL8 secretion was significantly increased by D. farinae extract and all TLR ligands
apart from LPS. Calcitriol significantly decreased CXCL8 secretion, and coadministration
with D. farinae extract reduced CXCL8 concentrations to levels seen in unstimulated
sublingual epithelial cells. Although detectable, TGF-β1 secretion could not bemodulated
by any of the stimuli. Interleukin 6 and IL-10 could not be detected at the protein or at the
mRNA level. It can be concluded that a D. farinae extract and TLR ligands augment the
secretion of the proinflammatory chemokine CXCL8, whichmight interfere with sublingual
desensitization. On the other hand, CXCL8 secretion was reduced by coapplication of
calcitriol and a D. farinae extract. Calcitriol therefore seems to be a suitable candidate to
be used as adjuvant during sublingual immunotherapy.
Keywords: sublingual, epithelium, Dermatophagoides farinae, Toll-like receptor, calcitriol, CXCL8, dog, sublingual
immunotherapy
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INTRODUCTION
Allergen-specific immunotherapy (ASIT) is currently the only
therapy able to alter the immunopathological reactions during
allergies, teaching the immune system to tolerate the specific
allergen (1). Sublingual immunotherapy (SLIT) is a form of
ASIT during which allergens are administered under the tongue
onto the sublingual epithelium (2, 3). Epithelial cells are
known to be immunologically responsive and to influence the
behavior of surrounding immune cells. For instance in allergic
disease, epithelial cells can secrete interleukin 25 (IL-25), IL-
33, and thymic stromal lymphopoietin (TSLP), which promote
proallergenic responses (4, 5). House dust mites are one of the
most important allergen sources, causing respiratory allergies
in humans (6) and atopic dermatitis in dogs (7). House dust
mite allergens are known to interact with Toll-like receptors
(TLRs) and protease-activated receptors expressed by epithelial
cells. This induces proinflammatory and proallergenic mediator
production in human airway epithelial and epidermal cell
cultures (8–11) and contributes to disease development in mouse
asthma models (12–14). However, whether sublingual epithelial
cells are responsive to house dust mite allergen extracts has not
been assessed.
During SLIT, the use of tolerance-promoting adjuvants
has been suggested to improve the number of successfully
treated patients and to expedite the clinical onset of allergen-
specific desensitization (15). Toll-like receptor ligands have
been proposed as such adjuvants. In a mouse asthma model,
sublingual coadministration of an antigen and the synthetic
TLR2 ligand Pam3CSK4 decreased airway hyperresponsiveness
and reduced antigen-specific T helper 2 (TH2) responses in
the draining cervical lymph nodes (16). In addition, ex vivo
exposure of human peripheral blood mononuclear cells to
TLR2 ligands reduced their IL-5, IL-13, and immunoglobulin
E (IgE) production (17, 18), suggesting a suppressing effect
of TLR2 ligands on TH2-mediated responses. Apart from
TLR2, TLR4 ligands were reported to have a beneficial
effect during ASIT for pollen allergy, improving clinical
symptoms and inducing protective allergen-specific IgG
antibodies in humans (19). The most active form of vitamin
D3, calcitriol (1,25-dihydroxyvitamin D3), has also been
proposed as adjuvant for SLIT. It was shown to stimulate
the production of the anti-inflammatory cytokine IL-10 in
human and mouse dendritic cells (20, 21) and to induce
intracellular FoxP3 expression in T lymphocytes, a transcription
factor expressed by tolerance-promoting regulatory T cells
(22). During SLIT, adjuvants are directly applied onto the
sublingual epithelium; still, the effect of TLR ligands and
calcitriol on the activity of sublingual epithelial cells has not
been investigated.
To evaluate whether extracts of house dustmites canmodulate
immune responses in canine primary sublingual epithelial cells
and to evaluate the effect of potential adjuvants during SLIT,
sublingual epithelial cells were isolated from biopsies, cultured,
and characterized, and the effect of allergens, TLR ligands
and calcitriol on the viability, cytokine production, and gene
expression by these cells was assessed.
MATERIALS AND METHODS
Isolation of Canine Primary Sublingual
Epithelial Cells and Sublingual
Subepithelial Cells
Sublingual biopsies of ∼0.5 × 0.5 cm were sampled within
3 h after euthanasia from six privately owned dogs that
were euthanized for medical reasons unrelated to the study
(Supplementary Table A). Oral consent to use the corpse
for scientific purposes was given by all dog owners. Of
one dog, one-half of the sublingual biopsy was processed
for immunohistochemistry. This sample was submerged in
Methocel R© MC (Merck, Burlington, MA, USA), snap-frozen
in liquid nitrogen, and stored at −80◦C. To isolate sublingual
cells, biopsies were briefly submerged in 70% ethanol, washed
three times with Ca2+-free and Mg2+-free Dulbecco phosphate-
buffered saline (DPBS; Thermo Fisher Scientific, Waltham, MA,
USA) and incubated in 4 mg/mL Dispase II (Thermo Fisher
Scientific) in DPBS on ice. After 16- to 24-h incubation, the
epithelial layer was carefully separated from the underlying
subepithelial tissue, followed by incubation of the epithelial
and subepithelial tissue in DPBS with 0.25% trypsin (Thermo
Fisher Scientific) and 2.65mM EDTA for 20min at room
temperature (RT; 18◦C−22◦C). Subsequently, cell suspensions
were resuspended, trypsin was neutralized with an equal volume
of 5% fetal calf serum (FCS) (Merck) in DPBS, and the cells were
filtered over a 70-µm cell strainer (Merck). After centrifugation
(400 g, 10min, 18◦C), cells were counted and 2.5 × 105
cells/cm2 were seeded in a culture flask in sublingual epithelial
cell culture medium [SECCM; ¾ Dulbecco modified eagle
medium (DMEM), ¼ nutrient mixture F12-Ham [Thermo Fisher
Scientific], 5% FCS, 2 nM 3,3′,5-triiodo-L-thyronine sodium salt,
5µg/mL recombinant human insulin, 10 ng/mL recombinant
human epidermal growth factor, 0.4µg/mL hydrocortisone,
100 nM L-isoproterenol hydrochloride [Merck], 100 U/mL
penicillin, 100µg/mL streptomycin, and 100µg/mL gentamicin
[Thermo Fisher Scientific]) (23, 24). During the first 7 days
of culture, the SECCM was supplemented with 2.5µg/mL
amphotericin B (Thermo Fisher Scientific), and medium was
changed daily. Thereafter, medium was replaced every 2 to 3
days. Cells were expanded, split (0.25% trypsin, 1mM EDTA in
DPBS) at 70 to 90% confluence, and used at passages 2 to 7 for
the experiments. The sublingual epithelial cells were shown to
be free ofMycoplasma infection during routine testing using the
LookOut R© Mycoplasma PCR Detection Kit (Merck) according
to the manufacturer’s instructions.
Immunofluorescence Staining of
Sublingual Tissue
Cryosections (10µm) of the frozen tissue (LEICA CM3050 S
Microtome; Leica, Wetzlar, Germany) on APES-coated glass
slides were fixed in acetone for 10min at −20◦C and stained
to assess the expression of the integrin subunit α6 (CD49f).
In subsequent steps, slides were incubated with PBS + 1%
bovine serum albumin (BSA) + 5% goat serum (Merck)
at RT for 30min, with 10µg/mL rat anti–human CD49f
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(NKI-GoH3, Thermo Fisher Scientific) or the rat IgG2a anti-
KLH control (isotype control; Biolegend, San Diego, CA, USA)
for 1 h and with fluorescein isothiocyanate (FITC)–conjugated
goat anti–rat IgG (Merck) for 1 h. In between each step,
slides were washed with PBS supplemented with 1% BSA.
Counterstaining of the nuclei occurred with Hoechst (Thermo
Fisher Scientific). Slides were analyzed using a Leica Leitz DMR
fluorescence microscope (Leica). Images were processed using
ImageJ (25).
Flow Cytometry
Sublingual epithelial or subepithelial cells (5.0× 104) were added
to conical bottomed wells of a 96-well plate. Ten µg/mL rat anti–
human CD49f or isotype control in PBS + 1% BSA was added
in a volume of 50 µL for 20min on ice. Washing of the cells was
followed by addition of 50 µL of 0.6µg/mL Alexa Fluor R© 647–
conjugated goat anti–rat IgG (Biolegend) in PBS + 1% BSA for
20min on ice. After two washing steps, cells were resuspended
in 100 µL DPBS and analyzed by flow cytometry (CytoFLEX;
Beckman Coulter, Brea, CA, USA) using the CytExpert 2.0
software (Beckman Coulter). Singlets were gated in a forward
scatter area and height plot, followed by discrimination of cell
debris in a forward- and side-scatter plot. Expression of CD49f
was assessed by measuring the relative fluorescence intensity for
Alexa Fluor R© 647.
Stimulation of Canine Primary Sublingual
Epithelial Cells With House Dust Mite
Extracts, TLR Ligands, and Calcitriol
Canine primary sublingual epithelial cells were seeded in SECCM
in a 24-well plate at 30,000 cells/well and incubated overnight
at 37◦C and 5% CO2. Thereafter, a Dermatophagoides farinae
extract, a Dermatophagoides pteronyssinus extract, TLR ligands,
calcitriol, or control medium was added for 24 h to the cultured
cells; the supernatant was collected and stored at −20◦C. The
products, listed in Table 1, were added in a volume of 400
µL serum-free sublingual epithelial cell stimulation medium
(SECSM) (¾ DMEM, ¼ Ham’s F-12, 100 U/mL penicillin,
100µg/mL streptomycin, and 100µg/mL gentamicin). The D.
farinae and D. pteronyssinus extracts were prepared by the
manufacturer (Greer Laboratories, Lenoir, NC, USA) by crushing
whole mite bodies followed by a bilevel extraction at 1:10
and 1:5 wt/vol in 0.125M ammonium bicarbonate and dialysis
against distilled water. Because calcitriol was dissolved in ethanol,
the control wells for calcitriol contained an equal volume of
this solvent. To analyze the effect of the D. farinae extract
in combination with calcitriol, cells were incubated without
stimulus, with 20µg/mL D. farinae extract, or with both D.
farinae extract and 0.1µM calcitriol in SECSM. Additionally,
after 6-h incubation with 0.1µM calcitriol and 20µg/mL D.
farinae extract, sublingual epithelial cells were lysed in RLT
buffer (RNeasy mini kit; Qiagen, Hilden, Germany) and stored
at−80◦C.
MTT Assay
An MTT assay was used to evaluate the effect of the different
stimuli on the viability and metabolic activity of canine primary
TABLE 1 | Products added to the canine primary sublingual epithelial cells.
Group of
products
Name (specific
receptor)
Working
concentration
Supplier
Allergen
extract
Dermatophagoides
farina (XPB81D3A2.5,
lot: 307244)
20 µg dry
protein weight
(bradford
assay)/mL
(2.1µg/mL
Der f 1)
Greer laboratories,
Lenoir, NC, USA
Dermatophagoides
pteronyssinus
(XPB82D3A2.5,
lot: 346230)
20 µg dry
protein weight
(bradford
assay)/mL
(0.58µg/mL
Der p 1)
TLR ligands FSL-1 (TLR2) 1µg/mL Invivogen, San
Diego, CA, USA
Heat-killed Listeria
monocytogenes
(HKLM) (TLR2)
108 cells/mL
Pam3CSK4 (TLR2) 1µg/mL
Polyinosinic:polycytidylic
acid high molecular
weight (poly I:C HMW)
(TLR3)
10µg/mL
Polyinosinic:polycytidylic
acid low molecular
weight (poly I:C LMW)
(TLR3)
10µg/mL
LPS (Escherichia coli
K12) (TLR4)
10µg/mL
Vitamin D Calcitriol (vitamin D
receptor)
1–0.01µM Merck, Burlington,
MA, USA
sublingual epithelial cells. Five thousand cells/well in 200 µL
SECCM were seeded in wells of a 96-well cell culture plate. After
overnight incubation at 37◦C and 5% CO2, medium was replaced
by the products in Table 1 in SECSM. Following an additional
20-h incubation at 37◦C and 5% CO2, plates were developed as
described by Kieckens et al. (26), with some minor adjustments.
Briefly, 20 µL of 5 mg/mL MTT [3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide] in Hanks balanced salt
solution (Thermo Fisher Scientific) was added to each well,
followed by 4-h incubation (37◦C, 5% CO2). After removal of the
supernatant, the formed formazan crystals were dissolved in 1:1
(vol/vol) ethanol/dimethyl sulfoxide using gentle resuspension,
followed by measurement of the optical density (OD) at 560 nm
(OD1) and 620 nm (OD2). OD2 was subtracted from OD1,
and results were finally expressed as the percentage viable cells
by dividing OD values of the stimulated wells by those of the
unstimulated control.
Cytokine Enzyme-Linked Immunosorbent
Assays
The secretion of the proinflammatory cytokine IL-6, the
chemokine IL-8/CXCL8, and the anti-inflammatory cytokine
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IL-10 in cell-free supernatants was measured using canine-
specific DuoSet enzyme-linked immunosorbent assay (ELISA)
kits (R&D Systems, Minneapolis, MN, USA) according to the
manufacturer’s instructions. Human and canine transforming
growth factor β1 (TGF-β1) were shown to have high homology
(27), and therefore, the human TGF-β1 ELISA was used to detect
canine TGF-β1 (28).
RNA Extraction and RNA-Sequencing
RNA extraction and DNase treatment of the samples was
performed using the RNeasy mini kit and Rnase-Free DNase
Set (Qiagen) according to the manufacturer’s instructions.
Extracted RNA was stored at −80◦C. Total RNA concentration
was measured using the Quant-iT RiboGreen RNA Assay Kit
(Thermo Fisher Scientific). RNA quality was inspected using an
RNA 6000 Nano chip on a BioAnalyser (Agilent Technologies,
Santa Clara, CA, USA). For each sample, a sequencing library
was constructed using the QuantSeq 3′ mRNA-Seq Library Prep
Kit FWD for Illumina (Lexogen, Vienna, Austria) starting from
500 ng total RNA and amplified by 14 polymerase chain reaction
(PCR) cycles. Quality and size distribution of the libraries were
checked on a BioAnalyser (Agilent Technologies) using the high-
sensitivity Quant-iT dsDNAAssay Kit (Thermo Fisher Scientific)
and a high-sensitivity DNA chip. Library concentration was
determined according to Illumina’s Sequencing Library qPCR
Quantification Guide on a LightCycler 480 (Roche Life Science,
Penzberg, Germany). Sequencing of the libraries was done at
Ghent University’s NxtGnt sequencing facility as single-read
75 bp on a NextSeq 500 sequencer (Illumina, San Diego, CA,
USA) using four lanes per sample. Subsequently, sequencing
read quantity and quality were checked using FastQC (v0.11.8).
Contamination was determined using FastQ Screen (v0.14.0).
Adapter trimming and removal of reads having a quality score
lower than 20 or containing any ambiguities were done using
cutadapt (v2.5). The remaining high-quality reads were mapped
on the CanFam3.1 reference dog genome using STAR (v2.7.2),
and features were count at the gene level using RSEM (v1.3.1).
Statistical Analysis
Statistical analysis was performed using R [R Core Team (29)].
Normal distribution of the data was assessed using the Shapiro–
Wilk test and quantile–quantile plot. Log-transformed ELISA
concentrations and untransformed data of the MTT test were
normally distributed and analyzed using the paired Student t-test.
A p < 0.05 was considered statistically significant. Differential
expression analyses of the RNA-sequencing data were done in
R using the edgeR (v3.26.8) package. For each analysis, feature
counts were normalized using edgeR’s standard normalization
method. To remove uninformative low-count features, those
having < 1 cpm (counts per million) in the number of samples
equivalent to the size of the smallest group were discarded.
Statistical testing was done by fitting a general linear model,
followed by a quasi-likelihood F test. Differentially expressed
features were considered statistically significant when having
a fold change of at least 2 (doubling or halving between the
compared groups) and a false discovery rate (or adjusted p-value
according to Benjamini–Hochberg) smaller than or equal to 0.05.
FIGURE 1 | CD49f is expressed by canine sublingual epithelial, but not by
sublingual subepithelial cells. (A) Immunofluorescence of canine sublingual
tissue in which cryosections were stained with CD49f (FITC) and
counterstained with Hoechst. E = epithelium, S = subepithelial tissue. (B)
Histograms generated by flow cytometric analysis that are representative for all
donors. Isotype controls are given in red; stained cells are shown in green. (C)
Flow cytometric analysis: mean fluorescence intensity (MFI) of all samples
stained with CD49f for sublingual epithelial cells (n = 6) and subepithelial cells
(n = 4). Mean fluorescence intensity of the isotype control was subtracted
from the MFI of the stained cells. Horizontal bars indicate the mean.
RESULTS
A D. farinae Extract and TLR Ligands
Increase CXCL8 Secretion While Calcitriol
Suppresses It
To assess whether two house dust mite extracts might
modulate cytokine secretion by canine primary sublingual
epithelial cells, cells were isolated from sublingual biopsies.
Immunofluorescence staining and flow cytometry showed that
the isolated sublingual cells stained positive for the epithelial
marker CD49f (Figure 1).
Next, it was evaluated whether an allergen extract ofD. farinae
and D. pteronyssinus could alter the sublingual epithelial cells’
cytokine secretion. The D. farinae extract induced a significant
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increase in CXCL8 secretion as compared to the unstimulated
controls and D. pteronyssinus extract (Figure 2). Therefore, we
used this D. farinae extract to evaluate the effect of potential
adjuvants on the CXCL8 response.
Different potential adjuvants were tested for their direct
effect on cytokine secretion by canine sublingual epithelial cells.
The TLR2 ligands, FSL-1, HKLM, and Pam3CSK4, and TLR3
ligands, poly I:C high (HMW) and lowmolecular weight (LMW),
significantly increased CXCL8 secretion by sublingual epithelial
cells (p < 0.05; Figure 3). Calcitriol was able to significantly
suppress the CXCL8 secretion at concentrations of 1 and 0.1µM
(p < 0.05), but not at 0.01µM (Figure 4). The sublingual
epithelial cells constitutively produced TGF-β1 (unstimulated
control: 41 ± 15 pg/mL; median ± interquartile range), and
this did not change significantly when incubated with the D.
farinae extract, TLR ligands, or calcitriol (data not shown).
Neither unstimulated nor stimulated sublingual epithelial cells
detectably produced the proinflammatory cytokine IL-6 or the
anti-inflammatory cytokine IL-10.
Neither D. farinae extract at 20µg/mL, nor the TLR ligands
FSL-1 at 1µg/mL, HKLM at 108 cells/mL, Pam3CSK4 at
1µg/mL, lipopolysaccharide (LPS) at 10µg/mL, or calcitriol
at 0.1µM had a significant effect on cell viability after 24-
h incubation. Only poly I:C HMW (57% ± 12%; mean
± standard deviation) and LMW (73% ± 5%) significantly
decreased the viability of canine sublingual epithelial cells
(p < 0.001) (Figure 5).
Calcitriol Can Suppress CXCL8 Secretion
by Canine Sublingual Epithelial Cells Even
in the Presence of D. farinae
To investigate the effects of calcitriol on canine sublingual
epithelial cells when coadministered with the extract of D.
farinae, cells were incubated with D. farinae extract alone,
a combination of D. farinae extract with calcitriol, or with
medium without stimulus. Costimulation with calcitriol and D.
farinae significantly suppressed CXCL8 production as compared
to cells stimulated with D. farinae alone (p < 0.05). There
was no significant difference in CXCL8 secretion between
cells stimulated with D. farinae and calcitriol combined and
cells cultured without any stimulus, suggesting maintenance of
normal CXCL8 secretion levels (Figure 6).
Calcitriol Induces Glucocorticoid Receptor
and Prostaglandin E Synthase mRNA
Expression
No significantly differentially expressed genes could be identified
when comparing RNA-sequencing data of sublingual epithelial
cells incubated with and without D. farinae extract. Calcitriol,
however, did significantly upregulate 13 genes compared to
unstimulated cells, among which NR3C1, the glucocorticoid
receptor; CYP24A1, a cytochrome P450 that catabolizes vitamin
D; and PTGES, an enzyme that generates prostaglandin E
(Table 2). Interestingly, in all the conditions tested, transcript
counts of less than 1 count per million were observed for IL-1α,
IL-1β, IL-6, IL-10, IL-25, IL-33, and TSLP.
FIGURE 2 | A Dermatophagoides farinae extract significantly increases
CXCL8 secretion by canine sublingual epithelial cells (n = 6). The cells were
cultured for 24 h with 20µg/mL D. farinae extract or 20µg/mL D.
pteronyssinus extract and CXCL8 secretion was measured. *p < 0.05;
**p < 0.01 to control; paired Student t-test.
DISCUSSION
In this study, primary sublingual epithelial cells from dogs were
isolated from biopsies, cultured in vitro, and characterized for
expression of the marker CD49f. All sublingual epithelial cells
stained positive for this marker. This is in agreement with
findings in humans and dogs, which showed that CD49f is a
reliable marker to identify epithelial cells (30–33).
Canine sublingual epithelial cells were stimulated with a
D. farinae extract, a D. pteronyssinus extract, different TLR
ligands, and calcitriol to assess differences in their cytokine and
chemokine secretion profile. Only the production of CXCL8
could be significantly modulated. This proinflammatory
chemokine is capable of attracting neutrophils and T
lymphocytes (34, 35). The oral cavity contains low numbers
of proinflammatory effector cells (36, 37), and the absence of
proinflammatory signals likely explains the facilitated generation
of antigen-specific tolerance. During SLIT, allergens are
administered onto sublingual epithelial cells. These cells showed
a significant increase in CXCL8 secretion when stimulated
with a D. farinae extract. Also, in human and canine epidermal
keratinocytes, crude extracts of D. farinae and its allergenic
protein, Der f 1, increased the expression of proallergenic
mediators and proinflammatory cytokines (11, 38). It should be
noted that, in both cited studies, the allergen exposure protocol
was insufficiently documented, and that in the study of Maeda
et al. (38), the activation state and purity of the Der f 1 were not
assessed. It should also be mentioned that, in order to generate
more representative results for the sublingual epithelial cells, a
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mimic of the mucosal lining fluid and saliva could have been used
rather than serum-free medium. While another study showed
that D. pteronyssinus proteins can induce proinflammatory
cytokine expression in epithelial cells (8), the D. pteronyssinus
extract we used did not modulate cytokine secretion by the
sublingual epithelial cells. Differences in composition of the
mite extracts could explain this discrepancy in response (39).
Nonetheless, the D. farinae extract did induce CXCL8 secretion
by canine sublingual epithelial cells, which indicates that
application of such an extract onto the sublingual epithelium
has the potential to generate a proinflammatory response in the
oral mucosa.
When the effect of different TLR ligands was investigated,
the TLR2 ligands Pam3CSK4, HKLM, and FSL-1, and the TLR3
ligand, poly I:C, but not LPS, significantly stimulated CXCL8
secretion. In the past, TLR2 ligands were shown to be promising
adjuvants for allergy treatment in some studies (16–18), whereas
other studies with mouse asthma models showed that TLR2
ligands could enhance proallergenic responses (40, 41). In canine
epidermal keratinocytes, LPS and Pam3CSK4 also promoted the
secretion of proinflammatory and proallergenic mediators (42–
44). Additionally, the TLR3 ligand, poly I:C, had a significant
lethal effect on the sublingual epithelial cells, as was observed for
bronchial epithelial cells as well as in epidermal keratinocytes (45,
46). The use of TLR ligands during SLIT is therefore likely to have
a negative impact on the tolerance-promoting anti-inflammatory
environment of the oral mucosa.
Calcitriol or 1,25-dihydroxyvitamin D3 is a small lipophilic
molecule that easily penetrates cell membranes through
diffusion (22, 47), after which it can bind to the vitamin D
receptor of epithelial cells and regulate several genes (48).
Interestingly, in combination with the D. farinae extract,
calcitriol significantly reduced CXCL8 secretion by canine
sublingual epithelial cells. During SLIT, calcitriol therefore seems
promising to prevent an allergen extract–induced increase in
FIGURE 4 | Calcitriol significantly suppresses CXCL8 secretion by canine
sublingual epithelial cells (n = 6). The cells were stimulated with 1, 0.1, and
0.01µM calcitriol for 24 h, and CXCL8 secretion was measured by ELISA.
**p < 0.01 to control; paired Student t-test.
FIGURE 3 | Ligands for TLR2 and TLR3 significantly increase CXCL8 secretion by canine sublingual epithelial cells (n = 6). The cells were cultured for 24 h with
Pam3CSK4 at 1µg/mL, FSL-1 at 1µg/mL, HKLM at 108 cells/mL, poly I:C high (HMW) and low molecular weight (LMW) at 10µg/mL, and LPS at 10µg/mL, and
CXCL8 secretion was measured by ELISA. *p < 0.05; **p < 0.01 to control; paired Student t-test.
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FIGURE 5 | The TLR3 ligand poly I:C significantly decreases the viability of canine sublingual epithelial cells (n = 6). The cells were cultured for 24 h with 0.1µM
calcitriol, D. farinae extract at 20µg/mL, Pam3CSK4 at 1µg/mL, FSL-1 at 1µg/mL, HKLM at 108 cells/mL, poly I:C high (HMW) and low molecular weight (LMW) at
10µg/mL, and LPS at 10µg/mL, and the effect on cell viability was assessed using an MTT test. ***p < 0.001 to control; paired Student t-test. Error bars:
standard deviation.
FIGURE 6 | Coadministration of a D. farinae extract with calcitriol suppresses
CXCL8 secretion by canine sublingual epithelial cells (n = 6). The cells were
cultured with 20µg/mL D. farinae extract or a combination of 20µg/mL D.
farinae extract with 0.1µM calcitriol for 24 h, and CXCL8 secretion was
measured by ELISA. **p < 0.01; ***p < 0.001 to control; paired Student t-test.
TABLE 2 | Calcitriol-induced gene expression in canine sublingual epithelial cells
(n = 5). Cells were incubated with 0.1µM calcitriol for 6 h.
Gene Fold change Adjusted p-value
NR3C1 2.21 0.004
CYP24A1 500 0.008
C28H10orf90 5.65 0.008
PTGES 1.95 0.012
KALRN 1.59 0.013
HMOX1 3.82 0.022
OSGIN1 22.22 0.022
SLC4A7 2.23 0.027
SEMA4D 3.24 0.029
KIF26A 1.95 0.037
KCNK10 14.08 0.038
LMCD1 2.26 0.044
TMC7 1.94 0.045
Fold changes to the unstimulated control are given.
CXCL8 secretion by sublingual epithelial cells. Interestingly,
calcitriol significantly upregulated the mRNA expression of
NR3C1, the receptor for glucocorticoids. Indeed, calcitriol
and the glucocorticoid dexamethasone were shown to have
a combined tolerance-promoting effect when sublingually
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administered in a mouse model (21). Additionally, augmented
expression of the prostaglandin E–generating enzyme PTGES
was observed. Prostaglandin E has both proinflammatory and
anti-inflammatory properties, being capable of activating mast
cells (49), whereas secretion by bronchial epithelial cells has
an anti-inflammatory effect on murine dendritic cells (50).
Calcitriol can have an ambiguous effect on the proliferation of
human epithelial cells, with low concentrations (10−9–10−11 M)
promoting the proliferation of human epidermal keratinocytes,
whereas higher concentrations (>10−8 M) inhibited keratinocyte
proliferation in vitro (51, 52). However, in our hands, calcitriol
did not affect the viability and metabolic activity of canine
sublingual epithelial cells, as was shown for human bronchial
epithelial cells (53). Nevertheless, if calcitriol would be used as
an adjuvant during SLIT, the effects of repeated administration
on the oral mucosa should be investigated.
Although low concentrations of TGF-β1 could be detected
in canine sublingual epithelial cell supernatant, neither calcitriol
nor the TLR ligands or the D. farinae extract significantly
changed the secretion of this cytokine. In humans, calcitriol
was shown to induce TGF-β in epidermal keratinocytes (48),
whereas incubation of primary oral epithelial cells with bacteria
suppressed the secretion of this cytokine (54). In the context of
allergies, TGF-β generally leads to allergen-tolerating responses
by inducing regulatory T cells and promoting an isotype shift in B
cells in favor of IgA production (55, 56). Substances that increase
TGF-β secretion by sublingual epithelial cells would therefore be
interesting candidates for use as adjuvants during SLIT. While
production of IL-6 and IL-10 has been observed in other types
of epithelial cells (57–63), no secretion of these cytokines was
detected for canine sublingual epithelial cells by ELISA or RNA
sequencing. Furthermore, proallergenic mediators associated
with the epithelium, TSLP, IL-25, and IL-33 (4, 64) and the
proinflammatory cytokines IL-1α and IL-1β were not expressed
by canine sublingual epithelial cells. Whether this difference in
mediator expression compared to epithelial cells of other tissues
is due to specific properties of the canine sublingual epithelium
should be investigated.
In this study, canine sublingual epithelial cells were cultured
as a monolayer. However, the sublingual epithelium consists
of 12–18 layers in dogs (65). This difference might limit the
conclusions that can be drawn for in vivo applications. Indeed,
cytokine secretion repertoires of epidermal keratinocytes differed
when cultured as a monolayer compared to a more complex
multilayered culture model (39). Nevertheless, unlike the skin,
the canine sublingual epithelium is non-keratinized tissue, which
allows penetration of molecules to the level of the basal epithelial
cells to exert their effects (37, 65). This study therefore provides
relevant insights into which mediators can be produced by
sublingual epithelial cells positioned close to the basement
membrane, mediators that could influence the behavior of local
immune cells.
In conclusion, canine primary sublingual epithelial cells were
isolated from dogs and showed increased secretion of CXCL8
in response to a D. farinae extract, TLR2, and TLR3 ligands,
whereas the production of this chemokine could be suppressed
by calcitriol. Furthermore, when applied onto the cells together
with an extract of D. farinae, calcitriol downregulated CXCL8
concentrations to levels similar to those observed in unstimulated
sublingual epithelial cells. As such, calcitriol seems to be a
promising adjuvant for use during SLIT because it might help
to maintain the tolerance-inducing properties of the oral mucosa
during desensitizing treatments.
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